RHÖN-KLINIKUM Aktiengesellschaft (RHK.DE)
EUR 13.8
(-1.43%)
EUR 13.8
(-1.43%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 499.09 Million EUR | 10.05% |
| 2022 | 453.51 Million EUR | 2.88% |
| 2021 | 440.81 Million EUR | 0.31% |
| 2020 | 439.44 Million EUR | -1.49% |
| 2019 | 446.11 Million EUR | 3.73% |
| 2018 | 430.06 Million EUR | 24.25% |
| 2017 | 346.14 Million EUR | 0.96% |
| 2016 | 342.86 Million EUR | -34.79% |
| 2015 | 525.77 Million EUR | -5.33% |
| 2014 | 555.38 Million EUR | -61.2% |
| 2013 | 1.43 Billion EUR | -9.22% |
| 2012 | 1.57 Billion EUR | 0.02% |
| 2011 | 1.57 Billion EUR | 0.87% |
| 2010 | 1.56 Billion EUR | 8.88% |
| 2009 | 1.43 Billion EUR | 14.7% |
| 2008 | 1.25 Billion EUR | -3.97% |
| 2007 | 1.3 Billion EUR | 1.15% |
| 2006 | 1.28 Billion EUR | 27.2% |
| 2005 | 1.01 Billion EUR | 66.15% |
| 2004 | 609.69 Million EUR | 1.48% |
| 2003 | 600.77 Million EUR | 10.55% |
| 2002 | 543.43 Million EUR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 519.82 Million EUR | 4.15% |
| 2024 Q2 | 518.1 Million EUR | -0.33% |
| 2023 Q4 | 499.09 Million EUR | 1.25% |
| 2023 Q3 | 492.93 Million EUR | 2.23% |
| 2023 Q2 | 482.16 Million EUR | 2.03% |
| 2023 Q1 | 472.57 Million EUR | 4.2% |
| 2023 FY | 499.09 Million EUR | 10.05% |
| 2022 Q2 | 453.85 Million EUR | 1.8% |
| 2022 Q4 | 453.51 Million EUR | -1.24% |
| 2022 Q3 | 459.21 Million EUR | 1.18% |
| 2022 Q1 | 445.81 Million EUR | 1.13% |
| 2022 FY | 453.51 Million EUR | 2.88% |
| 2021 Q2 | 445.32 Million EUR | -1.62% |
| 2021 FY | 440.81 Million EUR | 0.31% |
| 2021 Q4 | 440.81 Million EUR | -2.02% |
| 2021 Q1 | 452.65 Million EUR | 3.0% |
| 2021 Q3 | 449.91 Million EUR | 1.03% |
| 2020 Q2 | 448.85 Million EUR | 0.21% |
| 2020 Q1 | 447.89 Million EUR | 0.4% |
| 2020 Q3 | 445.14 Million EUR | -0.83% |
| 2020 Q4 | 439.44 Million EUR | -1.28% |
| 2020 FY | 439.44 Million EUR | -1.49% |
| 2019 Q1 | 435.87 Million EUR | 1.35% |
| 2019 FY | 446.11 Million EUR | 3.73% |
| 2019 Q2 | 417.54 Million EUR | -4.2% |
| 2019 Q3 | 466.48 Million EUR | 11.72% |
| 2019 Q4 | 446.11 Million EUR | -4.37% |
| 2018 Q3 | 326.19 Million EUR | -10.77% |
| 2018 Q4 | 430.06 Million EUR | 31.84% |
| 2018 FY | 430.06 Million EUR | 24.25% |
| 2018 Q1 | 368.34 Million EUR | 6.41% |
| 2018 Q2 | 365.56 Million EUR | -0.75% |
| 2017 Q4 | 346.14 Million EUR | 1.64% |
| 2017 FY | 346.14 Million EUR | 0.96% |
| 2017 Q1 | 348.81 Million EUR | 1.74% |
| 2017 Q3 | 340.54 Million EUR | -1.4% |
| 2017 Q2 | 345.39 Million EUR | -0.98% |
| 2016 FY | 342.86 Million EUR | -34.79% |
| 2016 Q1 | 356.61 Million EUR | -32.17% |
| 2016 Q4 | 342.86 Million EUR | -3.52% |
| 2016 Q2 | 341.37 Million EUR | -4.27% |
| 2016 Q3 | 355.37 Million EUR | 4.1% |
| 2015 FY | 525.77 Million EUR | -5.33% |
| 2015 Q4 | 525.77 Million EUR | -25.14% |
| 2015 Q3 | 702.38 Million EUR | 35.92% |
| 2015 Q2 | 516.74 Million EUR | -3.45% |
| 2015 Q1 | 535.2 Million EUR | -3.63% |
| 2014 Q2 | 599.72 Million EUR | -30.04% |
| 2014 Q3 | 2.2 Billion EUR | 267.46% |
| 2014 Q1 | 857.29 Million EUR | -40.11% |
| 2014 Q4 | 555.38 Million EUR | -74.8% |
| 2014 FY | 555.38 Million EUR | -61.2% |
| 2013 Q2 | 1.43 Billion EUR | -7.73% |
| 2013 FY | 1.43 Billion EUR | -9.22% |
| 2013 Q1 | 1.55 Billion EUR | -1.69% |
| 2013 Q4 | 1.43 Billion EUR | 3.15% |
| 2013 Q3 | 1.38 Billion EUR | -2.99% |
| 2012 Q2 | 1.76 Billion EUR | 14.66% |
| 2012 Q3 | 1.55 Billion EUR | -11.78% |
| 2012 Q4 | 1.57 Billion EUR | 1.27% |
| 2012 FY | 1.57 Billion EUR | 0.02% |
| 2012 Q1 | 1.53 Billion EUR | -2.35% |
| 2011 Q3 | 1.47 Billion EUR | -3.95% |
| 2011 Q4 | 1.57 Billion EUR | 6.67% |
| 2011 FY | 1.57 Billion EUR | 0.87% |
| 2011 Q1 | 1.54 Billion EUR | -1.46% |
| 2011 Q2 | 1.53 Billion EUR | -0.1% |
| 2010 Q4 | 1.56 Billion EUR | 3.14% |
| 2010 FY | 1.56 Billion EUR | 8.88% |
| 2010 Q1 | 1.49 Billion EUR | 3.9% |
| 2010 Q3 | 1.51 Billion EUR | 0.45% |
| 2010 Q2 | 1.5 Billion EUR | 1.15% |
| 2009 Q4 | 1.43 Billion EUR | 0.0% |
| 2009 FY | 1.43 Billion EUR | 14.7% |
| 2008 FY | 1.25 Billion EUR | -3.97% |
| 2007 FY | 1.3 Billion EUR | 1.15% |
| 2006 FY | 1.28 Billion EUR | 27.2% |
| 2005 FY | 1.01 Billion EUR | 66.15% |
| 2004 FY | 609.69 Million EUR | 1.48% |
| 2003 FY | 600.77 Million EUR | 10.55% |
| 2002 FY | 543.43 Million EUR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Fresenius Medical Care AG & Co. KGaA | 19.1 Billion EUR | 97.387% |
| Fresenius SE & Co. KGaA | 25.63 Billion EUR | 98.053% |
| LIMES Schlosskliniken AG | 16.6 Million EUR | -2905.609% |
| M1 Kliniken AG | 69.72 Million EUR | -615.764% |
| Maternus-Kliniken Aktiengesellschaft | 206.49 Million EUR | -141.701% |
| MEDICLIN Aktiengesellschaft | 742.57 Million EUR | 32.789% |
| VITA 34 AG | 135.58 Million EUR | -268.118% |